Due to the dynamic nature of the Biotechnology market, a reorganisation of GRI's internal sales structure has resulted in the closure of GRI's Contract Services Division. The new structure of GRI's sales divisions allows clear focus on core business arenas, namely cellular and molecular biotechnology instrumentation and applications.

Sole UK agency products distributed via Contract Services have been reallocated to the cellular and molecular biology divisions to ensure ongoing sales and product support continues.